Saved in:
| Main Authors: | Kaifeng Jin, Jingtong Xu, Xiaohe Su, Ziyue Xu, Bingyu Li, Ge Liu, Hailong Liu, Yiwei Wang, Yu Zhu, Le Xu, Weijuan Zhang, Zhaopei Liu, Zewei Wang, Yuan Chang, Jiejie Xu |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | https://pathsocjournals.onlinelibrary.wiley.com/doi/10.1002/path.6266 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
POLQ identifies a better response subset to immunotherapy in muscle‐invasive bladder cancer with high PD‐L1
by: Ge Liu, et al.
Published: (2024)
by: Ge Liu, et al.
Published: (2024)
TP53 mutations in urothelial carcinoma: not all one and the same†
by: Alexis R Barr, et al.
Published: (2024)
by: Alexis R Barr, et al.
Published: (2024)
Immunohistochemistry‐based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapy
by: Csilla Olah, et al.
Published: (2025)
by: Csilla Olah, et al.
Published: (2025)
Natural killer cell infiltration elicits gender‐dependent dichotomous clinical outcomes in urothelial carcinoma
by: Lingkai Zhang, et al.
Published: (2025)
by: Lingkai Zhang, et al.
Published: (2025)
HHLA2 is more significantly associated with poor prognosis in TSCC than PD‐L1
by: Yi Li, et al.
Published: (2024)
by: Yi Li, et al.
Published: (2024)
DNA ‐hypermethylated human gastric cancer circumvents apoptosis in the absence of TP53 mutation
by: Yasunobu Mano, et al.
Published: (2025)
by: Yasunobu Mano, et al.
Published: (2025)
Corrigendum to “Combination of downregulating FEN1 and PD ‐1 blockade enhances antitumor activity of CD8 + T cells against HNSCC cells in vitro”
Published: (2024)
Published: (2024)
Patterns of structural variants within TP53 introns and relocation of the TP53 promoter: a commentary†
by: Hannah C Beird, et al.
Published: (2024)
by: Hannah C Beird, et al.
Published: (2024)
PD ‐ L1 ‐Inhibitor‐Associated Hidradenitis Suppurativa
by: Annie Jin, et al.
Published: (2026)
by: Annie Jin, et al.
Published: (2026)
Rapid and sensitive detection of Pseudomonas syringae pv. actinidiae causing bacterial canker of kiwifruit using recombinase‐aided amplification with lateral flow dipstick assay
by: Hailong Liu, et al.
Published: (2024)
by: Hailong Liu, et al.
Published: (2024)
Automated tumor immunophenotyping predicts clinical benefit from anti‐PD‐L1 immunotherapy
by: Xiao Li, et al.
Published: (2024)
by: Xiao Li, et al.
Published: (2024)
Tubal ligation exacerbates ovulation‐driven TP53 mutagenesis and p53 signatures by depleting protective menstrual hemoglobin
by: Kanchana Subramani, et al.
Published: (2026)
by: Kanchana Subramani, et al.
Published: (2026)
Sarcomatoid areas of urothelial carcinoma are enriched for CD163‐positive antigen‐presenting cells
by: Burles A Johnson, et al.
Published: (2025)
by: Burles A Johnson, et al.
Published: (2025)
Role of LncRNA UCA1 in OSCC CAFs : PD ‐ L1 Upregulation and Tumor Progression
by: Nisha Zhu, et al.
Published: (2025)
by: Nisha Zhu, et al.
Published: (2025)
Clinical outcomes and immune contexture in SMARCA4 ‐deficient gastric cancer patients
by: Mengyao Sun, et al.
Published: (2025)
by: Mengyao Sun, et al.
Published: (2025)
Aristolochic acid‐related renal cell carcinoma exhibits a distinct tumor‐immune microenvironment favoring response to immune checkpoint blockade
by: Po‐Hung Lin, et al.
Published: (2024)
by: Po‐Hung Lin, et al.
Published: (2024)
The involvement of epidermal growth factor receptor/protein kinase B signaling in the tumor intrinsic PD‐L1‐induced malignant potential of oral squamous cell carcinoma
by: Eri Sasabe, et al.
Published: (2024)
by: Eri Sasabe, et al.
Published: (2024)
Involvement of KEAP1/NRF2 pathway in non‐BRAF mutated squamous cell carcinoma of the thyroid
by: Elin Schoultz, et al.
Published: (2025)
by: Elin Schoultz, et al.
Published: (2025)
Tumor immune microenvironment in odontogenic carcinomas: Evaluation of the therapeutic potential of immune checkpoint blockade
by: Kyu‐Young Oh, et al.
Published: (2024)
by: Kyu‐Young Oh, et al.
Published: (2024)
Gastric cancer immune microenvironment score predicts neoadjuvant chemotherapy efficacy and prognosis
by: Shaoji Zhao, et al.
Published: (2024)
by: Shaoji Zhao, et al.
Published: (2024)
KMT2D deficiency potentiates antitumor immunity and sensitizes immune checkpoint blockade in urologic cancers
by: Yuedian Ye, et al.
Published: (2025)
by: Yuedian Ye, et al.
Published: (2025)
Overexpression of m 7 G writers METTL1 and BUD23 confers oncogenicity in kidney renal clear cell carcinoma
by: Anni Su, et al.
Published: (2025)
by: Anni Su, et al.
Published: (2025)
Inverse Regulation of TLR4 and PD ‐ L1 Shapes the Inflammatory Tumor Microenvironment in Oral Squamous Cell Carcinomas
by: Camila Alves Ferri, et al.
Published: (2025)
by: Camila Alves Ferri, et al.
Published: (2025)
Increased Expression of AXL and c‐MET in High‐Grade Clear Cell Renal Cell Carcinoma and Its Association With VEGFR‐TKI Treatment and PD‐L1 Expression
by: Shuji Mikami, et al.
Published: (2025)
by: Shuji Mikami, et al.
Published: (2025)
ATM immunohistochemistry as an effective screening method for POLE variants among endometrial carcinomas lacking mismatch repair deficiency and p53 abnormalities
by: Xinyi Huang, et al.
Published: (2026)
by: Xinyi Huang, et al.
Published: (2026)
NMRK2 is an efficient diagnostic indicator for Xp11.2 translocation renal cell carcinoma
by: Huayi Feng, et al.
Published: (2024)
by: Huayi Feng, et al.
Published: (2024)
Podocyte YAP ablation decreases podocyte adhesion and exacerbates FSGS progression through α3β1 integrin
by: Guangze Shao, et al.
Published: (2024)
by: Guangze Shao, et al.
Published: (2024)
Use of UV mutational signatures to distinguish between cutaneous and pulmonary primary squamous cell carcinoma
by: Jeffrey S. Ross, et al.
Published: (2024)
by: Jeffrey S. Ross, et al.
Published: (2024)
H 2 S ‐Mediated GH3 .1 Persulfidation Regulates IAA Homeostasis to Enhance Nodulation Formation and Nitrogen Fixation in Robinia pseudoacacia
by: Weiqin Zhang, et al.
Published: (2025)
by: Weiqin Zhang, et al.
Published: (2025)
Activated immune infiltrates expand opportunities for targeted therapy in p53‐abnormal endometrial carcinoma
by: Spencer D Martin, et al.
Published: (2025)
by: Spencer D Martin, et al.
Published: (2025)
Loss of Mist1 alters the characteristics of Paneth cells and impacts the function of intestinal stem cells in physiological conditions and after radiation injury
by: Yujun Huang, et al.
Published: (2025)
by: Yujun Huang, et al.
Published: (2025)
Clinicopathological importance of Bcl‐2 and p53 in postmenopausal triple‐negative breast carcinoma and association with age
by: Kei Ito, et al.
Published: (2024)
by: Kei Ito, et al.
Published: (2024)
The growth‐promoting effects of Bacillus amyloliquefaciens W82T‐44 on soybean and its biocontrol potential against soybean Phytophthora root rot
by: Haixu Liu, et al.
Published: (2024)
by: Haixu Liu, et al.
Published: (2024)
A deep‐learning workflow to predict upper tract urothelial carcinoma protein‐based subtypes from H&E slides supporting the prioritization of patients for molecular testing
by: Miriam Angeloni, et al.
Published: (2024)
by: Miriam Angeloni, et al.
Published: (2024)
Histone deacetylase 6 inhibition attenuates pathological cardiac hypertrophy by promoting autophagy through MAP1LC3B ubiquitination
by: Jiayu Yao, et al.
Published: (2025)
by: Jiayu Yao, et al.
Published: (2025)
Synchronous endometrial/cervical and ovarian/fallopian tube carcinoma: a genome‐wide mutation analysis
by: Lihong Li, et al.
Published: (2025)
by: Lihong Li, et al.
Published: (2025)
Contribution of tumour and immune cells to PD‐L1 expression as a predictive biomarker in metastatic triple‐negative breast cancer: exploratory analysis from KEYNOTE‐119
by: Javier Cortes, et al.
Published: (2024)
by: Javier Cortes, et al.
Published: (2024)
ZmNPSN 13 Potentiates Maize Rough Dwarf Disease Upon Recruitment by the RBSDV P 7‐1 Effector
by: Suining Deng, et al.
Published: (2026)
by: Suining Deng, et al.
Published: (2026)
Multiomics sequencing and immune microenvironment characteristics define three subtypes of small cell neuroendocrine carcinoma of the cervix
by: Baoyue Pan, et al.
Published: (2024)
by: Baoyue Pan, et al.
Published: (2024)
Beyond driver mutations: exploring the landscape of mutational signatures in adenocarcinomas of the bladder†
by: Tibor Szarvas, et al.
Published: (2024)
by: Tibor Szarvas, et al.
Published: (2024)
Similar Items
-
POLQ identifies a better response subset to immunotherapy in muscle‐invasive bladder cancer with high PD‐L1
by: Ge Liu, et al.
Published: (2024) -
TP53 mutations in urothelial carcinoma: not all one and the same†
by: Alexis R Barr, et al.
Published: (2024) -
Immunohistochemistry‐based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapy
by: Csilla Olah, et al.
Published: (2025) -
Natural killer cell infiltration elicits gender‐dependent dichotomous clinical outcomes in urothelial carcinoma
by: Lingkai Zhang, et al.
Published: (2025) -
HHLA2 is more significantly associated with poor prognosis in TSCC than PD‐L1
by: Yi Li, et al.
Published: (2024)